Showing results (961-970 of 1,294) with videos related to
Sort By:
Pageof 130
Paediatric Drugs|July 18, 2019
Facilitating Informed Permission/Assent/Consent in Pediatric Clinical TrialsSusan M Abdel-RahmanPaediatric Drugs|April 18, 2024
Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic ReviewSebastiano A G Lava, Craig Laurence, Alessandro Di Deo, et al.Paediatric Drugs|August 29, 2014
Statin use in Australian children: a retrospective audit of four pediatric hospitalsIngrid C Gelissen, Huy Long Nguyen, Darren K Tiao, et al.Paediatric Drugs|June 9, 2016
Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in BelgiumLaetitia Gerlier, Mark Lamotte, Sofia Dos Santos Mendes, et al.Paediatric Drugs|September 2, 2017
Management of Supraventricular Tachycardia in InfantsChalese Richardson, Eric S SilverPaediatric Drugs|August 3, 2017
Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance DatabaseGeneviève Durrieu, Mathieu Maupiler, Vanessa Rousseau, et al.Paediatric Drugs|July 20, 2017
A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future ResearchMarilena M DeMayo, Yun Ju C Song, Ian B Hickie, et al.Paediatric Drugs|June 15, 2016
Managing Inflammatory Manifestations in Patients with Chronic Granulomatous DiseaseAlessandra Magnani, Nizar MahlaouiPaediatric Drugs|September 13, 2017
Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in JapanTomoko Kashiwagi, Yukiko Okada, Ken NomotoPaediatric Drugs|April 22, 2016
Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in NeonatesGeorgi Nellis, Tuuli Metsvaht, Heili Varendi, et al.Pageof 130